DaBomb Protein Biotech Corp. (TPEX:6578)
Taiwan · Delayed Price · Currency is TWD 18.10
+0.15 (0.84%)
Aug 19, 2026, 10:05 AM CST
DaBomb Protein Biotech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 339.44 | 309.34 | 337.82 | 384.41 | 433.63 | 470.63 | |
Revenue Growth | 13.87% | -8.43% | -12.12% | -11.35% | -7.86% | -22.24% |
Cost of Revenue | 258.65 | 240.3 | 269.1 | 337.99 | 414.3 | 448.98 |
Gross Profit | 80.8 | 69.04 | 68.73 | 46.43 | 19.33 | 21.65 |
Selling, General & Admin | 88.14 | 80.99 | 55.6 | 62.77 | 69.95 | 73.61 |
Research & Development | 14.17 | 16.23 | 14.95 | 13.59 | 11.85 | 11.82 |
Operating Expenses | 102.3 | 97.22 | 70.55 | 76.36 | 81.8 | 85.42 |
Operating Income | -21.51 | -28.18 | -1.82 | -29.93 | -62.47 | -63.77 |
Interest Expense | -2 | -3.07 | -5.21 | -8.23 | -6.58 | -4.58 |
Interest & Investment Income | 1 | 1.8 | 5.02 | 6.33 | 2.37 | 2.44 |
Currency Exchange Gain (Loss) | 0.52 | 0.52 | 14.89 | -0.82 | 15.68 | -6.86 |
Other Non Operating Income (Expenses) | 28.43 | 3.19 | 3.17 | 2.36 | 1.87 | 1.15 |
EBT Excluding Unusual Items | 6.44 | -25.75 | 16.05 | -30.29 | -49.13 | -71.62 |
Gain (Loss) on Sale of Investments | 0.22 | 0.22 | -0.02 | -0.07 | - | - |
Gain (Loss) on Sale of Assets | -0.16 | -0.16 | 0.04 | -25.59 | 0.05 | - |
Asset Writedown | -40.65 | -40.65 | - | - | - | - |
Other Unusual Items | 0 | 0 | - | - | 0.03 | - |
Pretax Income | -34.15 | -66.34 | 16.07 | -55.95 | -49.06 | -71.62 |
Income Tax Expense | 7.76 | 3 | 4.43 | 1.08 | -4.39 | -9.17 |
Net Income | -41.91 | -69.34 | 11.64 | -57.03 | -44.66 | -62.45 |
Net Income to Common | -41.91 | -69.34 | 11.64 | -57.03 | -44.66 | -62.45 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 74 | 72 | 67 | 54 | 39 | 32 |
Shares Outstanding (Diluted) | 74 | 72 | 72 | 54 | 39 | 32 |
Shares Change | 4.58% | 0.11% | 34.30% | 38.27% | 19.16% | -0.13% |
EPS (Basic) | -0.57 | -0.96 | 0.17 | -1.07 | -1.15 | -1.92 |
EPS (Diluted) | -0.57 | -0.96 | 0.17 | -1.07 | -1.15 | -1.92 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | 25.25 | -21.04 | 17.32 | -12.37 | -0.29 | -376.35 |
Free Cash Flow Per Share | 0.34 | -0.29 | 0.24 | -0.23 | -0.01 | -11.59 |
Dividend Per Share | - | - | 0.170 | 0.550 | 1.000 | - |
Dividend Growth | - | - | -69.09% | -45.00% | 450.05% | - |
Gross Margin | 23.80% | 22.32% | 20.34% | 12.08% | 4.46% | 4.60% |
Operating Margin | -6.34% | -9.11% | -0.54% | -7.79% | -14.41% | -13.55% |
Profit Margin | -12.35% | -22.41% | 3.45% | -14.83% | -10.30% | -13.27% |
Free Cash Flow Margin | 7.44% | -6.80% | 5.13% | -3.22% | -0.07% | -79.97% |
EBITDA | 23.39 | 10.5 | 10.44 | -9.98 | -37.48 | -39.81 |
EBITDA Margin | 6.89% | 3.39% | 3.09% | -2.60% | -8.64% | -8.46% |
D&A For EBITDA | 44.9 | 38.68 | 12.27 | 19.95 | 25 | 23.96 |
EBIT | -21.51 | -28.18 | -1.82 | -29.93 | -62.47 | -63.77 |
EBIT Margin | -6.34% | -9.11% | -0.54% | -7.79% | -14.41% | -13.55% |
Effective Tax Rate | - | - | 27.57% | - | - | - |